Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)
ABBOTT MEDICAL · Decision date Oct 30, 2026
What did the FDA decide?
FDA records this as supplement P140009/S144 to the original PMA P140009 for Abbott Medical’s Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG). The entry is a 30-Day Notice for a process change, not a new PMA approval or a statement of clinical performance.
The source names the changed item as an animal-derived to non-animal derived EBS lubricant used in TPU resin production for the BLE antenna manufacturing process. The stated scope is limited to the BLE antenna in the IPG for the bundled DBS and SCS devices; the record does not provide the technical reason for the change or any new safety or effectiveness data.
FDA approval order statement
animal-derived to non-animal derived EBS [Ethylene Bis-stearamide] lubricant to be used in TPU [thermoplastic polyurethane] resin production for the BLE [Bluetooth low energy] antenna manufacturing process. This applies specifically to the BLE antenna used in the IPG [implantable pulse generator] for either bundled device; DBS [Deep Brain Stimulator] and SCS [Spinal cord Stimulator]
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Oct 30, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P140009/S144
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- MHY
- Decision code
- OK30
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.
- Applicant
- Abbott Medical
- Product code
- MHY
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P140009. Subsequent supplements may change the device or its indications.
FDA decision timeline
P140009 · Original PMA
BRIO NEUROSTIMULATION SYSTEM
P140009/S140 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger
P140009/S139 · Related supplement
Infinity DBS IPG
P140009/S144 received
Application receipt date recorded by FDA.
P140009/S143 · Related supplement
Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generator
P140009/S141 · Related supplement
Deep Brain Stimulation (DBS) EPG
P140009/S142 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger
P140009/S144 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P140009. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140009
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BRIO NEUROSTIMULATION SYSTEMP140009 | ABBOTT MEDICAL | PMA approval | Jun 12, 2015 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 11, 2026 | FDA | |
Infinity DBS IPGP140009/S139 | ABBOTT MEDICAL | PMA supplement | Sep 23, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 27, 2026 | FDA | |
Deep Brain Stimulation (DBS) EPGP140009/S141 | ABBOTT MEDICAL | PMA supplement | Oct 28, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code MHY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Nov 8, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 30, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 6, 2026 | FDA | |
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEMP960009/S546 | Medtronic, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 6901 Prestion Rd., Plano, TX, 75024
Sources and methodology
- Original FDA record: P140009/S144
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
